A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience

Int J Cardiol. 2016 Dec 1:224:454-455. doi: 10.1016/j.ijcard.2016.09.022. Epub 2016 Sep 15.
No abstract available

Keywords: Atrial fibrillation; Cardioversion; Real life; Rivaroxaban; Transesophageal echocardiography; Trombus.

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / therapy*
  • Drug Administration Schedule
  • Drug Monitoring / methods
  • Echocardiography, Transesophageal / methods
  • Electric Countershock* / adverse effects
  • Electric Countershock* / methods
  • Female
  • Humans
  • International Normalized Ratio / methods
  • Male
  • Middle Aged
  • Premedication / methods*
  • Rivaroxaban / administration & dosage*
  • Stroke / etiology
  • Stroke / prevention & control*
  • Treatment Outcome
  • Warfarin / administration & dosage

Substances

  • Anticoagulants
  • Warfarin
  • Rivaroxaban